XML 60 R49.htm IDEA: XBRL DOCUMENT v2.4.0.6
RELATED PARTY TRANSACTIONS (Details Textual) (USD $)
3 Months Ended 47 Months Ended 1 Months Ended 6 Months Ended 8 Months Ended 12 Months Ended 20 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 1 Months Ended 3 Months Ended 12 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 37 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 12 Months Ended 3 Months Ended 3 Months Ended 12 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Dec. 31, 2012
Jun. 30, 2011
Investor Warrants [Member]
Feb. 29, 2012
Minimum [Member]
Feb. 29, 2012
Maximum [Member]
Jun. 30, 2010
Ensisheim Partners Llc [Member]
Dec. 31, 2009
Ensisheim Partners Llc [Member]
Dec. 31, 2012
Ensisheim Partners Llc [Member]
Dec. 31, 2009
Ensisheim Partners Llc [Member]
Dec. 31, 2010
Ensisheim Partners Llc [Member]
Jun. 30, 2010
Ensisheim Partners Llc [Member]
Royalty Payments Expense [Member]
Dec. 31, 2010
Robert L.Kelly [Member]
Mar. 31, 2013
Dr.Hunkapiller [Member]
Dec. 31, 2011
Dr.Hunkapiller [Member]
Dec. 31, 2011
Dr.Hunkapiller [Member]
Stock Option and Incentive Plan 2010 [Member]
Oct. 11, 2012
Board Of Directors Chairman and Chief Executive Office [Member]
Mar. 31, 2012
Board Of Directors Chairman and Chief Executive Office [Member]
Dec. 31, 2012
Board Of Directors Chairman and Chief Executive Office [Member]
Jul. 30, 2012
Board Of Directors Chairman and Chief Executive Office [Member]
Mar. 31, 2011
Board Of Directors Chairman and Chief Executive Office [Member]
Nov. 03, 2010
Board Of Directors Chairman and Chief Executive Office [Member]
Jun. 30, 2010
Board Of Directors Chairman and Chief Executive Office [Member]
Promissory Note One [Member]
May 16, 2011
Board Of Directors Chairman and Chief Executive Office [Member]
Promissory Note One [Member]
May 26, 2009
Board Of Directors Chairman and Chief Executive Office [Member]
Promissory Note One [Member]
May 31, 2011
Board Of Directors Chairman and Chief Executive Office [Member]
Promissory Note Two [Member]
Mar. 31, 2011
Board Of Directors Chairman and Chief Executive Office [Member]
Promissory Note Two [Member]
Jun. 30, 2010
Board Of Directors Chairman and Chief Executive Office [Member]
Promissory Note Two [Member]
Dec. 31, 2010
Board Of Directors Chairman and Chief Executive Office [Member]
Promissory Note Two [Member]
May 19, 2011
Board Of Directors Chairman and Chief Executive Office [Member]
Promissory Note Two [Member]
Dec. 31, 2012
Chief Executive Officer [Member]
Dec. 31, 2010
Chief Executive Officer [Member]
Dec. 31, 2010
Chief Executive Officer [Member]
Prior to Reverse Stock Split [Member]
Dec. 31, 2012
Chief Executive Officer [Member]
Research and Development Expense [Member]
Dec. 31, 2010
Former President [Member]
Dec. 31, 2012
Chief Scientific Officer [Member]
Dec. 31, 2010
Chief Scientific Officer [Member]
Dec. 31, 2010
Chief Scientific Officer [Member]
Prior to Reverse Stock Split [Member]
Dec. 31, 2012
Chief Scientific Officer [Member]
Research and Development Expense [Member]
Oct. 31, 2010
Chief Executive Officer and Chief Scientific Officer [Member]
Jan. 31, 2010
Chief Executive Officer and Chief Scientific Officer [Member]
Dec. 31, 2011
Chief Executive Officer and Chief Scientific Officer [Member]
Mar. 31, 2013
Chief Executive Officer and Chief Scientific Officer [Member]
Mar. 31, 2013
Chief Executive Officer and Chief Scientific Officer [Member]
Stock Option One [Member]
Mar. 31, 2013
Chief Executive Officer and Chief Scientific Officer [Member]
Stock Option Two [Member]
Dec. 31, 2011
Chief Executive Officer and Chief Scientific Officer [Member]
Research and Development Expense [Member]
Dec. 31, 2012
Employees and Officers [Member]
Mar. 31, 2013
Employees and Officers [Member]
Stock Option One [Member]
Mar. 31, 2013
Employees and Officers [Member]
Stock Option Two [Member]
Dec. 31, 2011
Employees and Officers [Member]
Stock Option and Incentive Plan 2010 [Member]
Mar. 31, 2013
Employees and Officers [Member]
Non-Qualified Stock Options Were Granted Under The 2010 Plan [Member]
Mar. 31, 2012
Employees and Officers [Member]
Non-Qualified Stock Options Were Granted Under The 2010 Plan [Member]
Dec. 31, 2012
Employees and Officers [Member]
Non-Qualified Stock Options Were Granted Under The 2010 Plan [Member]
Dec. 31, 2012
Employees and Officers [Member]
Non Qualified Stock Options Were Granted Outside Of 2010 Plan [Member]
Mar. 31, 2013
Non-Employee Director [Member]
Stock Option One [Member]
Feb. 29, 2012
Non-Employee Director [Member]
Stock Option One [Member]
Mar. 31, 2013
Non-Employee Director [Member]
Stock Option Two [Member]
Dec. 31, 2011
Non-Employee Director [Member]
Stock Option and Incentive Plan 2010 [Member]
Stock Option One [Member]
Dec. 31, 2012
Non-Employee Director [Member]
Stock Option and Incentive Plan 2010 [Member]
Stock Option Two [Member]
Short-term Debt                                                   $ 5,000                                                                    
Debt Instrument, Interest Rate, Stated Percentage                                             10.00% 10.00%         10.00%                                                              
Debt Instrument, Maturity Date                                               Dec. 31, 2010                                                                        
Interest Payable, Current                                                 439           8,959                                                          
Debt Instrument, Face Amount                                                         100,000                                                              
Loan Processing Fee                                                     4,000 4,000 4,000 4,000                                                            
Line of Credit Facility, Maximum Borrowing Capacity                                         500,000   500,000                                                                          
Line of Credit Facility, Interest Rate During Period                                       12.00%                                                                                
Line of Credit Facility, Current Borrowing Capacity                                       79,300   140,000                                                                            
Line of Credit Facility, Accrued Interest                                   1,440       6,093                                                                            
Line of Credit Facility, Periodic Payment, Principal                                   79,300 5,078                                                                                  
Exclusive License Agreement, Royalty Percentage                     2.00%                                                                                                  
Exclusive License Agreement, Minimum Royalty                     12,500                                                                                                  
Exclusive License Agreement, Minimum Royalty Increased                     25,000                                                                                                  
Patents Expenses                       16,250                                                                                                
Other Operating Income                         12,500                                                                                              
Operating Lease Annual Rent                 13,200                                                                                                      
Operating Leases, Rent Expense               6,600 248                                                                                                      
Security Deposit Related to Lease                 1,100   1,100                                                                                                  
Security Deposit Refund                   1,100                                                                                                    
Annual Base Salary                                                                 360,000     350,000   250,000                                            
Consulting Expense                           30,000                                                                                            
Salaries and Bonus                                                               322,590     161,295   243,554     243,554     693,048       492,095                          
Modified Annual Base Salary                                 45,000                               250,000         200,000                                            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 602,710                                                               250,000 565,830       100,000 226,332                       219,000     228,000 200,000       200,000 19,757
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights                                 (i) 11,250 option shares shall vest ninety (90) days after the date of grant; (ii) 11,000 option shares shall vest one hundred and eighty (180) days after the date of grant; (iii) 11,500 option shares shall vest two hundred and seventy (270) days after the date of grant; (iv) 11,250 option shares shall vest three hundred and sixty (360) days after the date of grant.                               25% (or 62,500 shares) vested on December 31, 2010 with the remaining 75% (or 187,500 shares) to vest in equal quarterly installments over the next three years so long as the executive remains employed with the company.         25% (or 25,000 shares) vested on December 31, 2010 with the remaining 75% (or 75,000 shares) to vest in equal quarterly installments over the next three years so long as the executive remains employed with the company.                         (i) twenty-five percent (25%) of the underlying shares on the first anniversary of the date of grant; and (ii) one-forty eighth (1/48) of the underlying shares monthly thereafter.     (i) twenty-five percent (25%) of the underlying shares on the first anniversary of the date employment commence; and (ii) one-sixteenth (1/16) of the underlying shares quarterly thereafter.         i) 80,000 option shares shall vest on September 1, 2011; (ii) 30,000 options shares shall vest on December 1, 2011; (iii) 30,000 options shares shall vest on March 1, 2012; (iv) 30,000 options shares shall vest on June 1, 2012; (v) 30,000 options shares shall vest on September 1, 2012.  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 1,650,299   1,650,299 1,051,636                                                         62,500         25,000                                            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding Number                                                                 187,500         75,000                                            
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Remaining Contractual Term                                 10 years                               5 years         5 years                         10 years     10 years 10 years       10 years 10 years
Share-based Compensation 274,512 44,882 566,776                                                                                                 274,512 44,882              
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $ 4.41                                                               $ 5.00         $ 5.00                         $ 1.25     $ 4.24 $ 4.11       $ 1.25 $ 6.00
Offer Price Per Share           $ 5.00 $ 7.00                                                                                                          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions Expected Forfeiture Rate, Description                                                                                               0.00% for the first year after the grant date, and 96.35% for every three months thereafter.                        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $ 2,237,318   $ 2,237,318 $ 1,150,416                                                                                                                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value                             $ 0.9060 [1] $ 0.906                                                 $ 2.756 $ 2.756   $ 3.00 $ 2.7560 [2] $ 6.57 [3]     $ 0.9060 [1] $ 4.11 [3]           $ 0.9060 [1]   $ 6.00 [4]    
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price         $ 1.60                   $ 1.25                                                           $ 5.00 $ 6.57     $ 1.25 $ 4.11           $ 1.25 $ 6.00 $ 6.00    
[1] The fair value of the Company's common stock was derived implicitly from the Private Placement during April through June 2011 at $1.25 per Unit, wherein one Unit was comprised of one share of common stock and one warrant to purchase one share of common stock at an exercise price of $1.60 per share.
[2] The fair value of the Company's common stock was derived implicitly from the public offering filed in March 2010 at $3.00 per share and from the terms of an underwritten offering contemplated in July 2010 at $6.00 per Unit that was filed in October 2010, with $2.756 per share being allocated to common stock using an iterative approach in order for the combined fair value of the common stock and warrants to equal the amount of consideration to be received for the offering.
[3] The fair values of the Company's common stock were derived from the closing prices on the NASDAQ Capital Market as of the dates of grant.
[4] The fair value of the Company's common stock was derived implicitly from the public offering filed in February 2012 at $6.00 per share.